TCRX TScan Therapeutics, Inc. Buxgalteriya kapitallashuvi

TCRX (TScan Therapeutics Inc) - kompaniyaning tovar belgisi

GURU.Markets platformasida TScan Therapeutics (TCRX) uchun narxlar grafigi hozirda 0.07 darajasida. Biznes shaxsiylashtirilgan immun terapiyalarini ishlab chiqish uchun ilmiy ittifoqlarga tayanadi. TScan Therapeutics (TCRX) biosafety va tadqiqot etikasi qoidalariga qat'iy rioya qilgan holda ESG tamoyillarini joriy etadi. Solid tumor terapiyasi segmentidagi operatsiyalar barqaror moliyalashtirish bilan ta'minlanmoqda, garchi o'sish sur'atlari FDA ning gen tahrirlashga oid qat'iy nazorati tufayli cheklangan bo'lsa-da.

TCRX TScan Therapeutics Balans kapitallashuvi (04.07.2022 - 27.10.2026)

TScan (TCRX) moliyaviy va bozor koʻrsatkichlari kesimi

- narx va narxlar bo'yicha konsensus prognoz:
Narxlar dinamikasi grafigi TScan Therapeutics|TCRX - Konsensus maqsadli narx
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor kapitallashuvi TScan Therapeutics Inc|TCRX - Korxona qiymati
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya uchun buxgalteriya qiymati TScan Therapeutics|TCRX - Balans kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati tscan.com|TCRX - Kompaniyaning jami aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning xususiy kapitalga nisbati TScan Therapeutics|TCRX - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati TScan Therapeutics|TCRX - Kompaniyaning jamlangan qarzlari|Balans qiymatiga qarzlar TScan Therapeutics Inc
Kompaniyaning jamlanma tahlili:TScan Therapeutics, Inc. - TCRX
tscan.com seriyali mahsuloti

T-hujayralar terapiyasi klinik sinovlari bilan bog'liq yuqori R&D xarajatlari TScan Therapeutics (TCRX) kompaniyasining foyda olmagan bosqichidagi maxsus moliyaviy profilini belgilaydi. Kitob kapitalizatsiyasi tendentsiyalarini tahlil qilish orqali investorlar majburiyatlar ayirilgan sof aktivlarning qiymatini baholaydilar, bu esa joriy operatsion foyda mavjud bo'lmagan holda kapitalni saqlash va bankrotlik xavfini monitoring qilish imkonini beradi.

TScan Therapeutics raqobatchilari

BeiGene Oncology (ONC) - Kompaniyaning buxgalteriya qiymati|Kompaniyaning sof aktivlari Halozyme Therapeutics|revmed.com (RVMD) - Buxgalteriya kapitallashuvi|Balans kapitallashuvi AAPG|Kompaniyaning sof aktivlari CG Oncology Inc|Balans kapitallashuvi URGN|Balans kapitallashuvi BCAX (Bicara Corp)|PSNL - Kompaniyaning balans qiymati|Buxgalteriya kapitallashuvi erasca.com ERAS|DCTH: Balans kapitallashuvi|YMAB - Kompaniyaning sof aktivlari|Balans kapitallashuvi AURA|CADL (Candel Therapeutics, Inc.) - Kompaniyaning xususiy kapitali|ARAY - Kompaniyaning balans qiymati|Kompaniyaning buxgalteriya qiymati SELLAS Life Sciences Group Inc. (SLS)|Actuate Therapeutics (ACTU) - Kompaniyaning sof aktivlari|Kompaniyaning buxgalteriya qiymati Citius Oncology Inc. (CTOR)|TuHURA Biosciences - Balans kapitallashuvi|TARA - Kompaniyaning sof aktivlari|Fate Therapeutics, Inc. - Kompaniyaning sof aktivlari|WHWK: Balans kapitallashuvi|Kompaniyaning balans qiymati championsoncology.com CSBR|XBiotech (XBIT) - Kompaniyaning buxgalteriya qiymati|Balans kapitallashuvi CVM (CEL-SCI Corp.)|Kompaniyaning xususiy kapitali OS Therapies, Inc. (OSTX)|Kompaniyaning sof aktivlari Radiopharm Theranostics Limited|Jami sof aktivlar ARTV (artivabio.com)|Kompaniyaning balans qiymati ANL|Biznesning balans bahosi Veru Inc VERU|TPST: Balans kapitallashuvi|XLO - Kompaniyaning sof aktivlari|RENB: Balans kapitallashuvi|MURA (Mural Oncology) - Balans kapitallashuvi|Kompaniyaning balans qiymati Kairos Pharma Limited (KAPA)|Buxgalteriya kapitallashuvi OnKure (OKUR)|CytoMed Therapeutics (GDTC) - Kompaniyaning sof aktivlari|Kompaniyaning buxgalteriya qiymati curis.com CRIS|Kompaniyaning sof aktivlari Apollomics (APLM)|Jami sof aktivlar tharimmune.com THAR|Balans kapitallashuvi Advanced Biomed Corp (ADVB)|GNPX - Kompaniyaning buxgalteriya qiymati|Balans kapitallashuvi CLDI|SBFM (Sunshine Biopharma Inc.) - Kompaniyaning xususiy kapitali|XBIO - Kompaniyaning balans qiymati|Kompaniyaning buxgalteriya qiymati salariuspharma.com|Balans kapitallashuvi PPBT|Balans kapitallashuvi AONC (aoncology.com)|BeOne Medicines (BGNE) - Kompaniyaning balans qiymati|Sof aktivlar qiymati Checkpoint Therapeutics Inc CKPT|ELEV (Elevation Oncology, Inc.) - Balans kapitallashuvi|iCAD, Inc. (ICAD) - Kompaniyaning xususiy kapitali|IKNA: Kompaniyaning sof aktivlari|Balans kapitallashuvi Notable Labs Ltd|Viracta Therapeutics Inc. (VIRX) - Kompaniyaning sof aktivlari|Jami sof aktivlar MorphoSys Corporation|NAYA (NAYA Biosciences) - Balans kapitallashuvi|Biznesning balans bahosi ascentage.com (AAPGV)